Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Where the A1C test came from

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

The A1C test exists because a few researchers noticed an unexplained extra fraction of haemoglobin, and then asked why diabetic patients had more of it.

The gap between that observation and routine clinical use was about two decades, and the thing that closed it was a trial about complications rather than a discovery about chemistry.

Related pages: Type 2 diabetes

The bottom line

What we know
  • Glycated haemoglobin was identified in the late 1950s as an unexplained minor fraction.
  • Its elevation in diabetes was reported in 1968.
  • Its use as a measure of average glucose control was proposed in 1976.
  • The DCCT trial tied A1C to complication risk and made it the standard measure.
  • International standardisation came later, which is why two reporting units remain in use.
What is still open
  • How much of the early resistance was technical and how much was conceptual.
  • Whether A1C will be displaced by continuous monitoring metrics.

The story, step by step

  1. 1. An odd band ()
  2. 2. The link ()
  3. 3. The proof ()
  4. 4. Two units ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 4

The accidental finding

Small or early study

What happens

Separation techniques revealed a minor fraction.

What the research shows

  • In the late 1950s, chromatographic separation of haemoglobin revealed small additional fractions alongside the main one, labelled A1a, A1b and A1c.
  • They were initially curiosities with no known significance, and considered possible artefacts.
  • The fractions turned out to be ordinary haemoglobin with glucose attached, a non-enzymatic process later called glycation.
  • Glycation happens continuously and irreversibly, in proportion to the surrounding glucose concentration.
  • This made the amount a record of average exposure over the lifespan of the red cell, though nobody framed it that way at first.

Why it matters

The test was not designed. It was found, and its usefulness was recognised later, which is a common pattern in laboratory medicine.

What's still uncertain

  • How long the fractions were dismissed as artefacts.

Read more

Next: The link

Part 2 of 4

Elevated in diabetes

Small or early study

What happens

1968, and then 1976.

What the research shows

  • In 1968, researchers reported that the A1c fraction was raised in patients with diabetes.
  • In 1976 it was proposed explicitly as an objective measure of long-term glucose control, at a time when the only tools were urine testing and occasional blood glucose readings.
  • This mattered because before it, clinicians had no way to know what had happened between visits, and patients' own accounts were the only record.
  • Uptake was slow. Assays were difficult, results varied between laboratories, and there was no agreed target.
  • Through the 1980s, A1C gradually entered specialist practice, still without a defined relationship to outcomes.

Why it matters

A measurement with no proven link to outcomes is hard to act on. That link was what the test still lacked.

What's still uncertain

  • How variable the early assays actually were.

Read more

Next: The proof

Part 3 of 4

DCCT and what followed

Small or early study

What happens

A trial about complications settled it.

What the research shows

  • The Diabetes Control and Complications Trial, reported in 1993, compared intensive with conventional glucose control in type 1 diabetes.
  • Intensive control dramatically reduced eye, kidney and nerve complications, and A1C was the measure used to express the difference.
  • Subsequent long-term follow-up of participants showed that early good control carried benefits for decades, the effect called metabolic memory.
  • A parallel study in type 2 diabetes reported in 1998 found that better glucose control reduced microvascular complications, with blood pressure control delivering large benefits as well.
  • These trials made A1C the currency of diabetes care: a number with a demonstrated relationship to the outcomes that matter.
  • A1C was not accepted for diagnosis, as opposed to monitoring, until 2009, once assay standardisation made the numbers comparable between laboratories.

Why it matters

The test became standard when it was tied to consequences. Until then it was a laboratory curiosity with clinical potential.

What's still uncertain

  • Whether intensive control in type 2 diabetes carries the same legacy effect.

Read more

Next: Two units

Part 4 of 4

Why the numbers differ by country

Small or early study

What happens

Standardisation arrived late.

What the research shows

  • Early results depended on the assay, so a value from one laboratory was not comparable with another's.
  • A standardisation program aligned assays to the methods used in the DCCT, which is why percentage values remain in use in the United States.
  • A separate international reference method produced values in millimoles per mole, adopted across much of Europe.
  • The two scales coexist: 6.5 percent equals 48 mmol/mol, and 7 percent equals 53.
  • Estimated average glucose was later introduced to translate A1C into units people recognise from their meters.
  • Continuous glucose monitoring has added time in range alongside A1C, the first serious addition to the measure in thirty years.

Why it matters

The persistence of two units is a historical accident, not a disagreement about the underlying chemistry.

What's still uncertain

  • Whether reporting will eventually converge on a single scale.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.